Literature DB >> 11194852

Use of antihypertensive drugs by Medicare enrollees: does type of drug coverage matter?

A S Adams1, S B Soumerai, D Ross-Degnan.   

Abstract

Research has demonstrated that Medicare beneficiaries with drug coverage consume more clinically essential drugs. However, generosity of coverage varies considerably across beneficiaries. This study examines the association between types of drug coverage and the consumption and cost per tablet of essential antihypertensive medications among beneficiaries with hypertension. The findings indicate that while both state- and employer-sponsored drug coverage are associated with greater consumption of antihypertensive drugs and lower out-of-pocket costs per tablet, private supplemental coverage is not associated with greater use and is associated with only slightly lower out-of-pocket costs than among noncovered beneficiaries.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11194852     DOI: 10.1377/hlthaff.20.1.276

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  23 in total

1.  Medicare prescription coverage and congressional gridlock.

Authors:  S B Soumerai; A S Adams; D Ross-Degnan
Journal:  J Gen Intern Med       Date:  2001-12       Impact factor: 5.128

2.  Cost-related medication nonadherence and spending on basic needs following implementation of Medicare Part D.

Authors:  Jeanne M Madden; Amy J Graves; Fang Zhang; Alyce S Adams; Becky A Briesacher; Dennis Ross-Degnan; Jerry H Gurwitz; Marsha Pierre-Jacques; Dana Gelb Safran; Gerald S Adler; Stephen B Soumerai
Journal:  JAMA       Date:  2008-04-23       Impact factor: 56.272

3.  Prescription drug coverage and effects on drug expenditures among elderly Medicare beneficiaries.

Authors:  Soonim Huh; Thomas Rice; Susan L Ettner
Journal:  Health Serv Res       Date:  2008-06       Impact factor: 3.402

4.  Drug use patterns in severely mentally ill Medicare beneficiaries: impact of discontinuities in drug coverage.

Authors:  Linda Simoni-Wastila; Ilene H Zuckerman; Thomas Shaffer; Christopher M Blanchette; Bruce Stuart
Journal:  Health Serv Res       Date:  2008-04       Impact factor: 3.402

5.  Potential savings from an evidence-based consumer-oriented public education campaign on prescription drugs.

Authors:  Julie M Donohue; Michael A Fischer; Haiden A Huskamp; Joel S Weissman
Journal:  Health Serv Res       Date:  2008-05-13       Impact factor: 3.402

Review 6.  Cost of pharmacological care of the elderly: implications for healthcare resources.

Authors:  Ciaran O'Neill; Carmel M Hughes; James Jamison; Anna Schweizer
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

Review 7.  Impediments to adherence to post myocardial infarction medications.

Authors:  Nihar R Desai; Niteesh K Choudhry
Journal:  Curr Cardiol Rep       Date:  2013-01       Impact factor: 2.931

8.  Health system factors and antihypertensive adherence in a racially and ethnically diverse cohort of new users.

Authors:  Alyce S Adams; Connie Uratsu; Wendy Dyer; David Magid; Patrick O'Connor; Arne Beck; Melissa Butler; P Michael Ho; Julie A Schmittdiel
Journal:  JAMA Intern Med       Date:  2013-01-14       Impact factor: 21.873

9.  Whom do older adults trust most to provide information about prescription drugs?

Authors:  Julie M Donohue; Haiden A Huskamp; Ira B Wilson; Joel Weissman
Journal:  Am J Geriatr Pharmacother       Date:  2009-04

10.  Income-, education- and gender-related inequalities in out-of-pocket health-care payments for 65+ patients - a systematic review.

Authors:  Sandro Corrieri; Dirk Heider; Herbert Matschinger; Thomas Lehnert; Elke Raum; Hans-Helmut König
Journal:  Int J Equity Health       Date:  2010-08-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.